Press Release: Transparency Notification from Shareholders
Transparency Notification from Shareholders Ghent, Belgium – 10 February 2025 – Sequana…
Ibex Medical Analytics Receives First FDA 510(k) Clearance
FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer…
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:30 ET | Source: Tempest Therapeutics BRISBANE, Calif., Feb.…
New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) --…
CERE Partners with BNP Paribas to Solarise ACTREC, Driving Sustainable Cancer Research
MUMBAI, India, Feb. 5, 2025 /PRNewswire/ -- On the occasion of World Cancer…
Patient Advocates from NCCN Guidelines Panels Share Their ‘United by Unique’ Stories for World Cancer Day
The National Comprehensive Cancer Network joins a global day of advocacy to…
Growing Incidence of Cancer is Denting the ‘Viksit Bharat 2047’ Vision – Global Sustainability Alliance Experts
Cancer cases in India will see a 57.7% increase by 2040, unless…
Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers.
LONDON, MUNICH and NEW DELHI, Feb. 3, 2025 /PRNewswire/ -- Datar Cancer Genetics…
BriaCell Therapeutics Announces Pricing of Public Offering
February 03, 2025 19:59 ET | Source: BriaCell Therapeutics Corp. PHILADELPHIA and…
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor…